Evotec stock.

Evotec SE is a publicly listed drug discovery and development company headquartered in Hamburg, Germany. The company operates globally, largely through external alliances with pharmaceutical and ... TecDAX, MDAX, Prime All Share, Late MDAX, Late TecDAX, Technology All Share, HDAX, CDAX, MDAX Kursindex, TecDAX Kursindex, BX Swiss - Aktien EMEA - Europa ...Mar 28, 2023 · Evotec and Bristol Myers Squibb, formerly Celgene, initiated the collaboration in 2016 to identify disease-modifying treatments for a broad range of neurodegenerative diseases. Evotec SE American Depositary Shares (EVO) Stock Price, Quote, News & History | Nasdaq MY QUOTES: EVO Edit my quotes Evotec SE American Depositary Shares (EVO) 0 Add to Watchlist Add...

Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) today announced the signing of a definitive agreement under which Evotec will acquire 100% of the capital of Rigenerand Srl, a leading cell technology company, for a purchase price of € 23 m. Founded in 2009 as a spin-off of …

Conference call scheduled for Monday, 31 July 2017, at 2.00 pm (CEST) to discuss transaction. Hamburg, Germany, and Greenwich, CT - 30 July 2017: Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) and Aptuit announced today that they have entered into a definitive agreement under which Evotec will acquire Aptuit for …

Evotec will facilitate the rapid development of Dewpoint's oncology assets using Evotec's clinical-enabling INDiGO platform to de-risk and accelerate the path to clinical testing.WebNov 28, 2023 · 0 brokerages have issued 1-year price objectives for Evotec's stock. Their EVT share price targets range from €21.00 to €34.00. On average, they expect the company's stock price to reach €28.00 in the next year. This suggests a possible upside of 70.2% from the stock's current price. View analysts price targets for EVT or view top-rated ... Evotec is designed to support your patients at every stage of their recovery and is fabricated utilizing the latest Biomechanic, Ergonomic, and Functional Technologies. Evotec is highly breathable and made of state-of-the-art materials that provide greater compression, support and comfort. Evotec is produced using a stitchless seam technique ...WebAug 29, 2023 · Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) today announced its financial results and corporate updates for the first half-year of 2023.

EVOTF | Complete Evotec SE stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

EVO is trading at a 18% discount. Price $10.56 Nov 20, 2023 Fair Value $86.83 Nov 20, 2023 Uncertainty High 1-Star Price $83.62

The latest Evotec stock prices, stock quotes, news, and EVO history to help you invest and trade smarter.5 thg 11, 2021 ... Evotec is an old player in the life sciences, but in offering new shares on the Nasdaq, the Germany-based company plans to bolster its new ...Immunology & Inflammation. Evotec has developed substantial expertise in the immunology and inflammation fields and has built through collaborations and partnerships a state-of-the-art integrated drug discovery platform covering all aspects from target identification to investigational new drug (“IND”). Our experienced immunology ...Stock Information; Financials; Publications; News; IR & ESG Events; Data protection for shareholders; Annual General Meeting Archive; Annual General Meeting; ESG; ... Germany [email protected] Postal address Göttingen site: Manfred Eigen Campus Marie-Curie-Str. 7 37079 Göttingen, Germany. T +49.(0)175.965.0267. [email protected] the latest Evotec SE ADR (EVO) stock price, news, historical charts, analyst ratings and financial information from WSJ.1 Wall Street research analysts have issued 12 month target prices for Evotec's shares. Their EVO share price targets range from $14.00 to $14.00. On average, they expect the company's stock price to reach $14.00 in the next twelve months. This suggests a possible upside of 49.1% from the stock's current price.

-1.58(-2.08%) Gold 2,091.70 +34.50(+1.68%) Advertisement Evotec SE (EVO) NasdaqGS - NasdaqGS Delayed Price. Currency in USD Follow 2W 10W 9M 9.96 -0.05 (-0.50%) At close: 03:59PM EST 9.47 -0.49... ENDLOS-TURBO PUT - EVOTEC (ZB_159808401.FRA) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Certificat ENDLOS-TURBO PUT - EVOTEC | Deutsche Boerse AG: | Deutsche Boerse AGConference call scheduled for Monday, 31 July 2017, at 2.00 pm (CEST) to discuss transaction. Hamburg, Germany, and Greenwich, CT - 30 July 2017: Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) and Aptuit announced today that they have entered into a definitive agreement under which Evotec will acquire Aptuit for …DDup. EVT Innovate Pipeline of product opportunities PanHunter Pharma partnerships R&D projects iPSC platform Evocells-Cell Therapy PRROTECT Operational Venturing BRIDGEs DDup. Our DDups ("Drug Discovery update") should give you the opportunity to get a better "look and feel" of what is going on at Evotec. Creating a better visibility of what ...WebAlternative stocks to Evotec (XTRA:EVT) ... For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. The higher the rank, the better the stock performs than its peers. And, we do this for six investment strategies: Value - shows how good of a value the stock is.5 thg 11, 2021 ... Evotec's mission is to discover and develop highly effective therapeutics ... ARK Invest's GREAT Analysis of Palantir Stock (PLTR). Ticker ...

Evotec SE (EVT.SWX) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Evotec SE | Swiss Exchange: EVT | Swiss Exchange 137b2813e93.au5c1amUyfGsQ1o5R_Emw9IyA2NnaClB8-5-AcP3X6k.B4ZquebAmMXcegh_Icd1pIpqVFMAJhA4q5srZ_K7LOEulBGZ0Pb8o50xDw

Stock Information; Financials; Publications; News; IR & ESG Events; Data protection for shareholders; Annual General Meeting Archive; Annual General Meeting; ESG; ... [email protected]. Contact us. Volker Braun SVP, Head of Global Investor Relations & ESG T +49 151 19405058 [email protected] vCard. Anika MeierEvotec has raised a total of. $741.7M. in funding over 13 rounds. Their latest funding was raised on Jun 2, 2023 from a Grant round. Evotec is registered under the ticker NASDAQ:EVO . Their stock opened with $21.75 in its …High-value iPSC research services. Patient-derived induced pluripotent stem cells (iPSCs) provide unique opportunities for drug discovery to identify new mechanisms of disease. Evotec has built an iPSC infrastructure that represents one of the largest and most sophisticated platforms in the industry. Evotec's iPSC platform has been developed ...16 hours ago · It seems that Private Companies own 6.5%, of the Evotec stock. It might be worth looking deeper into this. If related parties, such as insiders, have an interest in one of these private companies ... BONUS ZERTIFIKAT - EVOTEC (ZB_157528863.FRA) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Certificat BONUS ZERTIFIKAT - EVOTEC | Deutsche Boerse AG: | Deutsche Boerse AGWebNov 28, 2023 · 0 brokerages have issued 1-year price objectives for Evotec's stock. Their EVT share price targets range from €21.00 to €34.00. On average, they expect the company's stock price to reach €28.00 in the next year. This suggests a possible upside of 70.2% from the stock's current price. View analysts price targets for EVT or view top-rated ... Hamburg, Germany, 01 November 2023: Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) will announce its financial results for the first nine months 2023 on Wednesday, 08 November 2023. The Company is going to hold a conference call to discuss the results as well as provide an update on its performance.

Feb 15, 2023 · Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) announced today that Cyprotex US, LLC, the US site of Cyprotex a wholly owned subsidiary of Evotec, has completed its relocation from Watertown, MA to a new state-of-the-art facility in Framingham, MA, paving the way for significant further growth of its ...

View live EVOTEC SE INH O.N. chart to track its stock's price action. Find market predictions, EVT financials and market news. ... Evotec SE engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through the following segments: EVT Execute and EVT Innovate. ...

Evotec SE is a Germany-based drug discovery and development company. The company is engaged in development of new pharmaceutical products through research alliances and development partnerships with pharmaceutical and biotechnology companies, academic institutions, patient organizations and venture capital companies.Nov 1, 2023 · Hamburg, Germany, 01 November 2023: Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) will announce its financial results for the first nine months 2023 on Wednesday, 08 November 2023. The Company is going to hold a conference call to discuss the results as well as provide an update on its performance. TURBO UNLIMITED SHORT- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - EVOTEC (ZB_159285772.) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Certificat TURBO UNLIMITED SHORT- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - EVOTEC | Boerse Frankfurt Warrants: | Boerse Frankfurt WarrantsEvotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) and Dewpoint Therapeutics today announced a strategic R&D collaboration to advance Dewpoint’s leading oncology pipeline programmes of condensate modifying therapeutics (“c-mods”) to Investigational New Drug Applications …OPEN END TURBO OHNE STOP-LOSS - EVOTEC (ZB_51728826.) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Certificat OPEN END TURBO OHNE STOP-LOSS - EVOTEC | Börse Stuttgart: | Börse StuttgartEvotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809) today announced that the Company has entered into a multi-RNA target alliance with Takeda Pharmaceutical Company Limited (“Takeda”) with the goal to discover and develop RNA targeting small molecule therapeutics for highly attractive targets that …WebEvotec SE is a Germany-based drug discovery and development company. The company is engaged in development of new pharmaceutical products through research alliances and development partnerships with pharmaceutical and biotechnology companies, academic institutions, patient organizations and venture capital companies.Evotec SE stock information. Evotec SE is a company listed and traded on the London Stock Exchange under EVT.DEX. As of 29-11-2023, the stock price stands at 18.33 EUR. The market has seen 0.33 EUR change, representing 1.8333% change from the previous close of 18 EUR. EVT.DEX stock opened at 18.00 EUR, reached a high of 18.37 EUR, and a low of ...OPEN END TURBO OPTIONSSCHEIN SHORT - EVOTEC (ZB_159538242.) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Certificat OPEN END TURBO OPTIONSSCHEIN SHORT - EVOTEC | BOERSE MUENCHEN: | BOERSE MUENCHEN

Alternative stocks to Evotec (XTRA:EVT) ... For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. The higher the rank, the better the stock performs than its peers. And, we do this for six investment strategies: Value - shows how good of a value the stock is.Just – Evotec Biologics is an integrated design company focused on technologies that accelerate the discovery and development of high quality biotherapeutics and substantially reduce their manufacturing cost. At our core is a deeply experienced team with an understanding of the challenges that block access to these important therapeutics, and ...Alternative stocks to Evotec (XTRA:EVT) ... For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. The higher the rank, the better the stock performs than its peers. And, we do this for six investment strategies: Value - shows how good of a value the stock is.Instagram:https://instagram. asts stock forecastnyse abt newsamerican general life insurance ratingsmortgage brokers michigan Evotec SE is a Germany-based drug discovery and development company. The company is engaged in development of new pharmaceutical products through research alliances and development partnerships with pharmaceutical and biotechnology companies, academic institutions, patient organizations and venture capital companies.0.41%. $192.13B. EVO | A complete EVO overview by MarketWatch. View the latest market news and prices, and trading information.Web commercial real estate software marketbest financial advisors charleston sc When picking the best stocks under $10 to buy, it's important to identify fundamentally strong and non-speculative stocks. These are fundamentally strong and non-speculative stocks that are under $10 Since the meme stock euphoria in 2020, i...May 9, 2023 · Evotec SE (Frankfurt Stock Exchange: EVT, Prime Standard, ISIN: DE0005664809; NASDAQ: EVO) and Sandoz AG, a division of Novartis (NASDAQ: NVS) today announced that Evotecs Seattle-based subsidiary ... best options trading service Stock Information. In this section you will find detailed information regarding the Evotec SE share, ranging from basic share data over share price summary, stock price and charts, …WebFurther weakness as Evotec (ETR:EVT) drops 6.5% this week, taking three-year losses to 23%. Many investors define successful investing as beating the market average over the long term. But in any portfolio... Find the latest Evotec AG (EVT.DE) stock quote, history, news and other vital information to help you with your stock trading and investing.Nov 24, 2023 · The Evotec SE stock price gained 0.106% on the last trading day (Friday, 24th Nov 2023), rising from 18.79€ to 18.81€. During the last trading day the stock fluctuated 1.67% from a day low at 18.61€ to a day high of 18.92€. The price has risen in 6 of the last 10 days and is up by 7.8% over the past 2 weeks.